We’re pleased to announce the latest update to Mastermind CORE, our free genomic search platform, now featuring 10 newly added genes associated with rare and underdiagnosed conditions – including epilepsy, muscular dystrophy, inherited vision disorders, and more.

With this update, you can access 33 clinically significant genes through September 30, prior to the next quarterly rotation. This includes expertly curated variant interpretations, well-established gene-disease associations, and comprehensive literature-backed evidence – all designed to support more informed, timely clinical decisions.

Whether you’re advancing diagnostic accuracy, investigating pathogenic mechanisms, or prioritizing variants with clinical relevance, Mastermind CORE provides a curated foundation of genomic intelligence – purpose-built to elevate your work.

Newly added genes include:

Create a Mastermind Genomic Intelligence Platform account to instantly access the world’s most comprehensive, curated database of genomic literature—empowering faster, more accurate variant interpretation for clinical and research decisions.